G Tunevall

642 total citations
37 papers, 506 citations indexed

About

G Tunevall is a scholar working on Pharmacology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G Tunevall has authored 37 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G Tunevall's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Use and Resistance (5 papers) and Respiratory viral infections research (4 papers). G Tunevall is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Use and Resistance (5 papers) and Respiratory viral infections research (4 papers). G Tunevall collaborates with scholars based in Sweden, United Kingdom and France. G Tunevall's co-authors include B Brismar, Kevin Wickman, A.‐S. Malmborg, L. Bergman, Tommy Skau, Bengt Wretlind, P O Nyström, Erik Kihlström, Malin Jonsson Fagerlund and Nord Ce and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Cellular and Molecular Life Sciences and Journal of Antimicrobial Chemotherapy.

In The Last Decade

G Tunevall

31 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Tunevall Sweden 11 178 163 115 95 68 37 506
G. K. Daikos Greece 16 209 1.2× 252 1.5× 175 1.5× 140 1.5× 39 0.6× 63 648
Villy Frølund Thomsen Denmark 13 150 0.8× 155 1.0× 144 1.3× 111 1.2× 20 0.3× 30 557
H. Bradford Hawley United States 11 178 1.0× 136 0.8× 102 0.9× 172 1.8× 50 0.7× 26 538
A.P. Gillett United Kingdom 10 109 0.6× 286 1.8× 156 1.4× 74 0.8× 38 0.6× 22 463
A Thabaut France 11 126 0.7× 173 1.1× 208 1.8× 86 0.9× 56 0.8× 76 395
James N. Wilfert United States 8 77 0.4× 168 1.0× 184 1.6× 92 1.0× 15 0.2× 8 440
J. Michel Israel 15 151 0.8× 87 0.5× 97 0.8× 100 1.1× 36 0.5× 57 615
Cunha Ba United States 12 174 1.0× 98 0.6× 59 0.5× 98 1.0× 15 0.2× 51 474
D L Rotella United States 5 168 0.9× 185 1.1× 98 0.9× 109 1.1× 24 0.4× 10 352
Finegold Sm United States 13 113 0.6× 55 0.3× 48 0.4× 121 1.3× 24 0.4× 42 439

Countries citing papers authored by G Tunevall

Since Specialization
Citations

This map shows the geographic impact of G Tunevall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Tunevall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Tunevall more than expected).

Fields of papers citing papers by G Tunevall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Tunevall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Tunevall. The network helps show where G Tunevall may publish in the future.

Co-authorship network of co-authors of G Tunevall

This figure shows the co-authorship network connecting the top 25 collaborators of G Tunevall. A scholar is included among the top collaborators of G Tunevall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Tunevall. G Tunevall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brismar, B, A.‐S. Malmborg, G Tunevall, et al.. (1995). Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. Journal of Antimicrobial Chemotherapy. 35(1). 139–148. 63 indexed citations
2.
Ce, Nord, et al.. (1993). Effect of piperacillin/tazobactam treatment on human bowel microflora. Journal of Antimicrobial Chemotherapy. 31(suppl A). 61–65. 27 indexed citations
3.
Brismar, B, et al.. (1992). Effect of Piperacillin/Tazobactam Therapy on Intestinal Microflora. Scandinavian Journal of Infectious Diseases. 24(2). 209–213. 15 indexed citations
4.
Brismar, B, A.‐S. Malmborg, G Tunevall, et al.. (1992). Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrobial Agents and Chemotherapy. 36(12). 2766–2773. 111 indexed citations
5.
Meister, Björn, J Askergren, G Tunevall, H C Hemmings, & Paul Greengard. (1991). Identification of a dopamine- and 3′ 5′-cyclic adenosine monophosphate- regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland. Journal of Endocrinological Investigation. 14(8). 655–661. 15 indexed citations
6.
Tunevall, G. (1981). [New routines for prevention of postoperative infections. A review].. PubMed. 78(36). 3035–7.
7.
Urban, Teresa, Connie Jarstrand, & G Tunevall. (1981). The influence of opsonization with specific antibody and complement on the nitroblue tetrazolium (NBT) reduction of neutrophil granulocytes. A methodological study and a clinical application.. PubMed. 5(3). 175–9. 5 indexed citations
8.
Ekwall, Erik, Malin Jonsson Fagerlund, G Tunevall, et al.. (1980). Mecillinam and ampicillin separately or combined in gram-negative septicemia. Infection. 8(1). 37–40. 6 indexed citations
9.
Fagerlund, Malin Jonsson & G Tunevall. (1976). Selective pressure of tetracyclines on the faecal flora. A comparison between tetracycline and doxycycline.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 89–93. 4 indexed citations
10.
Fagerlund, Malin Jonsson & G Tunevall. (1975). FL 1039: A new β-lactam derivative for the treatment of infections with gram-negative bacteria. Infection. 3(1). 31–36. 8 indexed citations
11.
Böttiger, M, et al.. (1973). [Experiences from an outbreak of Salmonella paratyphi B].. PubMed. 70(36). 3048–50. 1 indexed citations
12.
Fagerlund, Malin Jonsson, Lars Rutberg, & G Tunevall. (1972). [R-factor mediated resistance to antibiotics in gram negative bacteria in Sweden].. PubMed. 69(37). 4105–8. 1 indexed citations
13.
Tunevall, G, et al.. (1968). Clinical evaluation of minocycline.. PubMed. 8. 335–9. 30 indexed citations
14.
Sterner, Gunnar, Heidi P. Fransen, G Tunevall, & Arne Svedmyr. (1967). A comparative trial of cephaloridine and erythromycin in hospitalized pneumonic patients.. PubMed. 43. Suppl 43:53–4. 10 indexed citations
15.
Tunevall, G, et al.. (1963). Aetiologic Agents in Respiratory Illness. Occurrence of Bacteria and of Serologic Reactions against Viruses and Bacteria in Acute Respiratory Illness.. 174(2). 11 indexed citations
16.
Lindner, Thomas & G Tunevall. (1963). Hypothermia and Infection. III. Influence of Hypothermia on the Course of Experimental Pneumococcal Infection in Mice. Scandinavian Journal of Clinical and Laboratory Investigation. 15(2). 125–131. 1 indexed citations
17.
Tunevall, G. (1959). Recent progress in microbiology : symposia held at the 7th International Congress for Microbiology, Stockholm, 1958. Almqvist & Wiksell eBooks. 2 indexed citations
18.
Tunevall, G & J. Wasserman. (1956). [The significance of bacterial findings in sputum].. PubMed. 53(8). 463–5. 1 indexed citations
19.
Ericsson, Hans, et al.. (1953). [Determination of chemoresistance of bacteria; principles of technic and evaluation].. PubMed. 50(9). 476–81. 1 indexed citations
20.
Tunevall, G, et al.. (1952). Otitis in Childhood a Clinical and Sero-Bacteriological Study with Special Reference to the Significance of Haemophilus Influenzae in Relapses. Acta Oto-Laryngologica. 42(4-5). 311–328. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026